The use of pharmacological chaperones in rare diseases caused by reduced protein stability
Autor: | Jon Gil‐Martínez, Ganeko Bernardo‐Seisdedos, José M Mato, Oscar Millet |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | PROTEOMICS. 22:2200222 |
ISSN: | 1615-9861 1615-9853 |
DOI: | 10.1002/pmic.202200222 |
Popis: | Rare diseases are most often caused by inherited genetic disorders that, after translation, will result in a protein with altered function. Decreased protein stability is the most frequent mechanism associated with a congenital pathogenic missense mutation and it implies the destabilization of the folded conformation in favour of unfolded or misfolded states. In the cellular context and when experimental data is available, a mutant protein with altered thermodynamic stability often also results in impaired homeostasis, with the deleterious accumulation of protein aggregates, metabolites and/or metabolic by-products. In the last decades, a significant effort has enabled the characterization of rare diseases associated to protein stability defects and triggered the development of innovative therapeutic intervention lines, say, the use of pharmacological chaperones to correct the intracellular impaired homeostasis. Here, we review the current knowledge on rare diseases caused by reduced protein stability, paying special attention to the thermodynamic aspects of the protein destabilization, also focusing on some examples where pharmacological chaperones are being tested. |
Databáze: | OpenAIRE |
Externí odkaz: |